Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Maui527on May 19, 2020 10:52am
228 Views
Post# 31045867

Know One Here Really Knows...

Know One Here Really Knows...What the true intrinsic value of the news that we recieved today!

You are all just retail tarders, looking for a quick pop and out you go. From slamming the President and anyone that you can take your frusttartions on.

KLY is a wonderful company with an incredibly bright future, but in it's infancy stage of development. For those here, like mysefl, that are playing the long game, news like today is incredibly well recieved and welcomed. For anyone else, it allows you all to cynical and short sighnted based on your own greed of instant gratification. 

If you stopped and truly reflected on what this all means and infinate potential laying in front of you, you would have a much different mindset.

Oh well, in life there are those with short visons and those with long visions....I play the latter!

Cheers Longs!
<< Previous
Bullboard Posts
Next >>